Verified source report
Seaport’s IPO adventure, obesity pill battles, and Makary’s troubles
This week on "The Readout LOUD" podcast: Seaport Therapeutics’ successful IPO, obesity pill battles, and the FDA commissioner's White House troubles.

What happened
According to STAT’s source item, Seaport’s IPO adventure, obesity pill battles, and Makary’s troubles, This week on “The Readout LOUD” podcast: Seaport Therapeutics’ successful IPO, obesity pill battles, and the FDA commissioner’s White House troubles.
Context
The development sits in VINI’s Science file for readers following research, health, climate, space, medicine, and scientific institutions. The original report is linked so readers can check the source account, follow later updates, and compare new coverage against the first published record. The source item is dated 2026-05-07T18:15:31+00:00.
What to watch
Open questions include whether primary sources issue follow-up statements, whether local or market impacts become clearer, and whether additional reporting changes the timeline or adds material context.
Source
Primary source: Seaport’s IPO adventure, obesity pill battles, and Makary’s troubles via STAT. VINI cites and links the source; it does not reproduce the publisher’s full article text without rights clearance.
This source-cited VINI report links to the original publisher record. VINI does not republish third-party article bodies without rights clearance. 1 source listed.
Source links
- Seaport’s IPO adventure, obesity pill battles, and Makary’s troublesSTAT - 2026-05-07T18:15:31+00:00
Reader comments
Moderated discussion
Comments are open to authenticated approved accounts, screened for spam and abuse, and published only after newsroom moderation unless editors change the story control.